These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 17381369)
1. New studies influencing treatment of heart failure: 2006 update. Dunlap ME Pharmacotherapy; 2007 Apr; 27(4 Pt 2):3S-11S. PubMed ID: 17381369 [TBL] [Abstract][Full Text] [Related]
2. How well are chronic heart failure patients being managed? Fonarow GC Rev Cardiovasc Med; 2006; 7 Suppl 1():S3-11. PubMed ID: 16955055 [TBL] [Abstract][Full Text] [Related]
3. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction. Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916 [TBL] [Abstract][Full Text] [Related]
4. The economic burden of congestive heart failure in a managed care population. Xuan J; Duong PT; Russo PA; Lacey MJ; Wong B Am J Manag Care; 2000 Jun; 6(6):693-700. PubMed ID: 10977478 [TBL] [Abstract][Full Text] [Related]
5. From cost of illness to cost-effectiveness in heart failure. Lévy E Eur Heart J; 1998 Dec; 19 Suppl P():P2-4. PubMed ID: 9886705 [TBL] [Abstract][Full Text] [Related]
6. Economic implications of treatment guidelines for congestive heart failure. Shibata MC; Nilsson C; Hervas-Malo M; Jacobs P; Tsuyuki RT Can J Cardiol; 2005 Dec; 21(14):1301-6. PubMed ID: 16341301 [TBL] [Abstract][Full Text] [Related]
7. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome. Gotsman I; Rubonivich S; Azaz-Livshits T Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235 [TBL] [Abstract][Full Text] [Related]
8. Advances in the treatment of heart failure with a preserved ejection fraction. Das A; Abraham S; Deswal A Curr Opin Cardiol; 2008 May; 23(3):233-40. PubMed ID: 18382212 [TBL] [Abstract][Full Text] [Related]
9. Effect of combination angiotensin-converting enzyme and angiotensin receptor blocker therapy on heart failure mortality and morbidity. Kapoor JR Am J Cardiol; 2008 Mar; 101(5):744-5. PubMed ID: 18308033 [No Abstract] [Full Text] [Related]
10. Health care and medication costs and use among older adults with heart failure. Stroupe KT; Teal EY; Weiner M; Gradus-Pizlo I; Brater DC; Murray MD Am J Med; 2004 Apr; 116(7):443-50. PubMed ID: 15047033 [TBL] [Abstract][Full Text] [Related]
11. Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy. Jneid H; Moukarbel GV; Dawson B; Hajjar RJ; Francis GS Am J Med; 2007 Dec; 120(12):1090.e1-8. PubMed ID: 18060931 [TBL] [Abstract][Full Text] [Related]
12. Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial. Caro JJ; Migliaccio-Walle K; O'Brien JA; Nova W; Kim J; Hauch O; Hillson E; Wedel H; Hjalmarson A; Gottlieb S; Deedwania PC; Wikstrand J; J Card Fail; 2005 Dec; 11(9):647-56. PubMed ID: 16360958 [TBL] [Abstract][Full Text] [Related]
13. Beta-adrenergic blocking drugs in severe heart failure. Fowler M Rev Cardiovasc Med; 2002; 3 Suppl 3():S20-6. PubMed ID: 12447158 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of beta-blocker treatment in heart failure. Gilbert EM Rev Cardiovasc Med; 2002; 3 Suppl 3():S42-7. PubMed ID: 12447161 [TBL] [Abstract][Full Text] [Related]
15. Strategies to improve the use of evidence-based heart failure therapies: OPTIMIZE-HF. Fonarow GC Rev Cardiovasc Med; 2004; 5 Suppl 1():S45-54. PubMed ID: 15184838 [TBL] [Abstract][Full Text] [Related]
16. The effects of angiotensin receptor antagonists on mortality and morbidity in heart failure--and an interaction with beta blockade. Coats AJ Int J Cardiol; 2001 Jan; 77(1):1-4. PubMed ID: 11150619 [No Abstract] [Full Text] [Related]
17. Pharmacologic advances in long-term heart failure management. Pfeffer MA Am Heart Hosp J; 2004; 2(4 Suppl 1):15-20. PubMed ID: 15539971 [TBL] [Abstract][Full Text] [Related]
18. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
19. Aldosterone receptor antagonism and heart failure: insights from an outpatient clinic. Mariotti R; Borelli G; Coceani M; Zingaro S; Barison A; Morelli I; Rondinini L J Clin Pharm Ther; 2008 Aug; 33(4):349-56. PubMed ID: 18613852 [TBL] [Abstract][Full Text] [Related]
20. [Chronic heart failure treatment in the year 2006]. De Berrazueta Fernández JR An R Acad Nac Med (Madr); 2006; 123(3):617-30. PubMed ID: 17451101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]